Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.31% | 198.00 | 1.2% | $508.85m | |
| GILD | Gilead Sciences, Inc. | 0.10% | 73.66 | 0.9% | $447.48m | |
| BIIB | Biogen Inc. | -0.07% | 330.71 | 1.3% | $368.34m | |
| CELG | Celgene Corporation | 0.10% | 82.66 | 1.2% | $330.77m | |
| ILMN | Illumina, Inc. | -1.24% | 317.70 | 3.5% | $286.85m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.40% | 378.78 | 2.6% | $220.81m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.74% | 122.84 | 2.0% | $210.28m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.63% | 180.18 | 1.9% | $202.20m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.46% | 132.41 | 16.4% | $168.86m | |
| A | Agilent Technologies, Inc. | 0.02% | 66.25 | 1.5% | $154.57m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.83% | 100.34 | 4.4% | $129.42m | |
| VKTX | Viking Therapeutics, Inc. | -1.59% | 14.23 | 0.9% | $107.03m | |
| LGND | Ligand Pharmaceuticals Incorporated | -1.64% | 199.27 | 23.3% | $106.37m | |
| NKTR | Nektar Therapeutics | 0.41% | 49.11 | 5.6% | $105.90m | |
| EXAS | Exact Sciences Corporation | -1.70% | 66.08 | 25.3% | $96.47m |
Company Profile
Neuralstem, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel and proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.